James C Smith insider trades

Open-market stock purchases and sales by James C Smith, Director at Pfizer Inc, from SEC Form 4 filings since Jan 4, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -21%.

Recent trades

DateStockTradeValue
Jun 26, 2026PFE Pfizer IncBought (not open market)$45K
Apr 23, 2026PFE Pfizer IncBought (not open market)$205K
Mar 27, 2026PFE Pfizer IncBought (not open market)$45K
Dec 31, 2025PFE Pfizer IncBought (not open market)$45K

Companies traded

  • PFE Pfizer Inc: 1 buy, 1 sale, last Jun 26, 2026
  • IT Gartner Inc: 65 sales, last Nov 26, 2024

Get free alerts when James C Smith files a new trade →